IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BVF Inc

Q1 2016 Holdings

Filed 2016-05-16 | 32 holdings | $38.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics Inc(CYTK)COM NEW23282W605$30.6M4,340,72978.9%
Cytomx Therapeutics Inc(CTMX)COM23284F105$7.8M606,13820.2%
Blueprint Medicines Corp(2L9)COM09627Y109$47.7K2,640,2510.1%
Concert Pharmaceuticals Inc(CNCEEUR)COM206022105$37.6K2,755,3180.1%
Forward Pharma A/SSPONSORED ADR34986J105$24.5K1,441,2870.1%
Oncothyreon IncCOM682324108$23.9K18,799,3680.1%
CTI Biopharma CorpCOM12648L106$23.8K44,796,9400.1%
Array Biopharma Inc(ARRYEUR)COM04269X105$23.2K7,850,2110.1%
Exelixis IncNOTE 4.250% 8/130161QAC8$22.7K$22,822,7780.1%
Chemocentryx Inc(CCXIEUR)COM16383L106$20.4K8,182,0520.1%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$19.2K1,755,7450.0%
Vitae Pharmaceuticals IncCOM92847N103$13.9K2,089,0140.0%
Oncomed Pharmaceuticals IncCOM68234X102$13.5K1,339,3360.0%
Arqule Inc(ARQLUSD)COM04269E107$12.6K7,893,3240.0%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$12.4K1,775,5720.0%
QLT IncCOM746927102$11.3K5,701,6090.0%
Esperion Therapeutics Inc NE(ESPR)COM29664W105$10.3K606,8010.0%
Tobira Therapeutics IncCOM88883P101$10.3K1,253,4010.0%
Celator Pharmaceuticals IncCOM15089R102$8.8K800,0000.0%
Nivalis Therapeutics IncCOM65481J109$6.5K1,546,7430.0%
GTX Inc delCOM40052B108$5.8K11,512,0000.0%
Pain Therapeutics IncCOM69562K100$4.8K2,149,9130.0%
Sunesis Pharmaceuticals IncCOM NEW867328601$2.6K4,813,2940.0%
Loxo Oncology IncCOM548862101$2.0K74,8700.0%
Array Biopharma IncNOTE 3.000% 6/004269XAA3$2.0K$2,500,0000.0%
Catalyst Biosciences IncCOM14888D109$1.6K970,9480.0%
Globeimmune Inc(GBIM)COM37957B100$1.4K657,6530.0%
Mast Therapeutics IncCOM576314108$1.0K3,696,9610.0%
Calithera Biosciences Inc(CALAEUR)COM13089P101$925162,9000.0%
Biota Pharmaceutials IncCOM090694100$526350,7760.0%
Ignyta IncCOM451731103$33950,0000.0%
Nephrogenex IncCOM640667101$184392,1560.0%